Table 5 Time trends of age-standardized mortality rates from common cancers among males in Serbia, 1991–2015, by joinpoint analysis
From: Cancer mortality in Serbia, 1991–2015: an age-period-cohort and joinpoint regression analysis
Cancer site | AAPC (95% CI) | Trend 1 | APC (95% CI) | Trend 2 | APC (95% CI) | Trend 3 | APC (95% CI) |
|---|---|---|---|---|---|---|---|
Lung | 1.0* (0.7 to 1.2) | 1991–2009 | 1.4* (1.1 to 1.6) | 2009–2015 | − 1.1 (− 2.4 to 0.2) | None | – |
Colon | 1.6* (1.3 to 1.8) | 1991–2009 | 2.0* (1.7 to 2.3) | 2009–2015 | − 0.3 (− 1.9 to 1.2) | None | – |
Stomach | − 2.1* (− 2.4 to − 1.8) | 1991–2009 | − 1.6* (− 1.9 to − 1.3) | 2009–2015 | − 4.6* (− 6.2 to − 2.9) | None | – |
Hematological malignancies | 0.7* (0.3 to 1.1) | 1991–1998 | − 3.0* (− 4.2 to − 1.9) | 1998–2007 | 3.0* (2.0 to 4.0) | 2007–2015 | − 0.4 (− 1.4 to 0.6) |
Brain | 1.2* (0.6 to 1.7) | 1991–1993 | 17.8 (− 5.9 to 47.6) | 1993–2015 | 0.8* (0.2 to 1.3) | None | – |
Bladder | 0.9* (0.4 to 1.3) | None | – | None | – | None | – |
Pancreas | 1.4* (1.1 to 1.7) | 1991–1993 | − 5.6 (− 17.5 to 1.3) | 1993–2015 | 1.6* (1.3 to 1.9) | None | – |
Prostate | 1.9* (1.4 to 2.3) | None | – | None | – | None | – |
Renal | 1.4* (0.9 to 1.8) | None | – | None | – | None | – |
All sites | 0.6* (0.5 to 0.8) | 1991–2009 | 0.9* (0.8 to 1.0) | 2009–2015 | − 0.9* (− 1.6 to − 0.2) | None | – |